The role of immune cells and immune checkpoints in multiple myeloma

Presented By: Nathalie Heider-Hönatsch, M.Sc.

Speaker Biography: Nathalie is currently a PhD student at the Department for Oncology, Immunology and Hematology at the University Hospital Bonn in Germany.
She is working in the biomedical research laboratory under the direction of Prof. Dr. Peter Brossart. Her thesis focuses on immunotherapy in multiple myeloma.

Webinar: The role of immune cells and immune checkpoints in multiple myeloma

Webinar Abstract: Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobulins in the bone marrow. We investigate the role of the PD-1/PD-L1 immune checkpoint during myeloma disease progression and determine combinatorial approaches of immunotherapeutic drugs to increase myeloma cell killing efficiency.

Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots (www.LabRoots.com)
2. Watch the webinar on YouTube or on the LabRoots Website (www.LabRoots.com)
3. Click Here to get your PACE credits (Expiration date – 11/21/2021): https://www.labroots.com/credi....t/pace-credits/3347/

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc